Literature DB >> 33633879

Frequency of Cardiovascular Manifestation in Patients With Hyperthyroidism.

Naresh Kumar Khurana1, Suresh Kumar2, Sameet Kumar3, Pardeep Kumar4, Amber Rizwan5.   

Abstract

Introduction Cardiovascular manifestations are very common in hyperthyroidism. Various cardiovascular symptoms such as palpitations, exercise intolerance, dyspnea, angina, edema, and congestive heart failure are commonly reported in hyperthyroidism. In this study, we determine the frequency of cardiovascular signs, symptoms, and various conduction disorders associated with hyperthyroidism. Methodology This cross-sectional, observational study was conducted in the cardiology department of a tertiary care hospital in Pakistan in close association with the internal medicine department from August 2019 to December 2019. A total of 100 hyperthyroid patients confirmed based on thyroid stimulating hormone (TSH, also known as thyrotropin), free T4 (FT4; thyroxine), and free T3 (FT3; triiodothyronine) were enrolled in the study. Results The most common cardiovascular symptom in this study was palpitations identified in 72% of the participants, followed by breathlessness in 41% of the participants. The most common cardiovascular sign was a pulse rate of more than 100 beats per minute found in 72% of the participants. The most common abnormality in electrocardiogram (ECG) was sinus tachycardia in 39% of the participants, followed by atrial fibrillation in 22% of the participants. In echocardiography, 5% of the participants had systolic dysfunction. Conclusion In this study, cardiovascular signs, symptoms, ECG, and echo changes were very frequent in hyperthyroidism. Management of hyperthyroidism should include routine ECG and echo testing, and cardiologists should be involved in thorough cardiovascular examination.
Copyright © 2021, Khurana et al.

Entities:  

Keywords:  cardiovascular symptoms; hyperthyroidism

Year:  2021        PMID: 33633879      PMCID: PMC7899246          DOI: 10.7759/cureus.12839

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  19 in total

Review 1.  Hyperthyroidism and the heart.

Authors:  Christos Panagoulis; Antonios Halapas; Evagelos Chariatis; Polixeni Driva; Evagelos Matsakas
Journal:  Hellenic J Cardiol       Date:  2008 May-Jun

Review 2.  Hyperthyroidism and thyrotoxicosis.

Authors:  Danielle Devereaux; Semhar Z Tewelde
Journal:  Emerg Med Clin North Am       Date:  2014-03-15       Impact factor: 2.264

Review 3.  Hyperthyroidism: a stepwise approach to management.

Authors:  Abdulraouf Ghandour; Carin Reust
Journal:  J Fam Pract       Date:  2011-07       Impact factor: 0.493

4.  Arterial embolism in thyrotoxicosis with atrial fibrillation.

Authors:  J S Staffurth; M C Gibberd; S N Fui
Journal:  Br Med J       Date:  1977-09-10

5.  Stroke in thyrotoxicosis with atrial fibrillation.

Authors:  P Petersen; J M Hansen
Journal:  Stroke       Date:  1988-01       Impact factor: 7.914

6.  Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.

Authors:  B Goichot; Ph Caron; F Landron; S Bouée
Journal:  Clin Endocrinol (Oxf)       Date:  2015-06-04       Impact factor: 3.478

7.  Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.

Authors:  E Kiss; G Jakab; E G Kranias; I Edes
Journal:  Circ Res       Date:  1994-08       Impact factor: 17.367

8.  [Hyperthyroidism and heart disease. Is thyrotoxic cardiomyopathy a disease entity?].

Authors:  P Toft; H E Bøtker
Journal:  Ugeskr Laeger       Date:  1993-05-03

9.  Effect of thyroid hormone on the distribution and activity of Na, K-ATPase in ventricular myocardium.

Authors:  Sriram Kasturi; Faramarz Ismail-Beigi
Journal:  Arch Biochem Biophys       Date:  2008-04-22       Impact factor: 4.013

10.  Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart.

Authors:  K Ojamaa; J D Klemperer; S S MacGilvray; I Klein; A Samarel
Journal:  Endocrinology       Date:  1996-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.